Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among Inpatients
Key facts
- Who runs it
- Jonathan Baghdadi
- Where
- Baltimore, United StatesSee the 2 sites
- Trial code
- Status
- Completed
- People taking part
- 107 people enrolled
- Started
- 1 Nov 2023
- Ended
- 31 May 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Electronic alert
- Structured communication of test results
- Record updated
- 14 April 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (5)Hide the full registry criteria
Who can take part
- Adult patients admitted to the University of Maryland Medical Center or University of Maryland Medical Center-Midtown Campus who are prescribed antibiotics for suspected community-acquired respiratory infection
- Protocol-based diagnostic testing supports possible viral infection, either by positive molecular test or low procalcitonin value
Who cannot take part
- Hospitalization for >72 hours prior to protocol-based diagnostic testing
- Previous molecular testing for viral infection during the same hospital encounter
- Severely immunosuppressed, defined as having hematologic malignancy, solid organ tumor on chemotherapy, or solid organ transplant on immunosuppression
Where in United States
- University of Maryland Medical CenterBaltimore, United States
- University of Maryland Medical Center - Midtown CampusBaltimore, United States
About the trial
What the trial wants to find out
The goal of this prospective randomized study is to improve antibiotic use among hospitalized patients with suspected pneumonia. An alert was built into the electronic health record to guide use of diagnostic testing based on probability of bacterial pneumonia. Patients with test results suggesting viral infection will be randomized to either: (1) receive a structured communication from the antimicrobial stewardship team to de-escalate antibiotics or (2) usual care.
The 2 groups in the trial
- Electronic alert plus structured communication of test resultsTreatment being tested
An electronic health record alert will guide diagnostic testing for pneumonia. For patients with low or moderate probability of bacterial pneumonia, test results will be communicated to the primary team with guidance to consider discontinuing or de-escalating antibiotics.
Treatment: Electronic alert and Structured communication of test results
- Electronic alert without structured communication of test resultsExisting treatment, for comparison
An electronic health record alert will guide diagnostic testing for pneumonia. The primary care team will access and interpret test results and decide upon composition and duration of antimicrobial without external guidance.
Treatment: Electronic alert
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among Inpatients: A Pragmatic, Randomized Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026
- Record updated
- 14 April 2026